QUESTIONS? CALL: +90(312)4728786
  • TR

Elis Ilac

Elis Ilac

Elis Ilac Company Description

T +90 (312) 472 87 86
Email: sales@elisilac.com

Elis Ilac
Ahmet Taner Kışlalı Mah. 2879. Sokak. Park Evleri Sitesi 2/2 Çayyolu-Çankaya-Ankara/TURKEY

Open in Google Maps
  • Home
  • Products
  • Our Services
  • About Us
  • Events
    • ExpoPharm
  • Blog
  • Contact Us
ASK
  • Home
  • Articles
  • 4% of the world’s population
July 6, 2022

4% of the world’s population

4% of the world’s population

by arioadmin / Monday, 28 October 2019 / Published in Articles

Created in 1997 by Inserm, Orphanet has progressively transformed into a Consortium of 40 countries, which are principally located in Europe. These partners work together to pool within it the available data on rare diseases taken from the scientific literature, making Orphanet the most comprehensive resource in the field. The large amounts of information it contains can improve the understanding of these conditions.

In their study, Rath’s team examined the data available on the point prevalence of 3,585 rare diseases (namely, the number of people affected at a given time). Rare cancers as well as rare diseases caused by infection or poisoning were excluded from their analysis.

After harmonizing the literature data using a predefined method, following which they added together the point prevalence of the various diseases referenced in the database, they were able to estimate that at any given time, 3.5 to 5.9% of the global population suffers from these conditions. This represents around 300 million people, i.e. 4% of the world’s population.

When taken together, “rare” diseases are not so rare after all, and therefore public health policies at global and national level are needed to address this issue, according to the authors. Such a policy is becoming reality in France, which launched its 3rd National Rare Diseases Plan a year ago. “In all likelihood, our data represent a low estimation of the reality. The majority of rare diseases are not traceable in healthcare systems and in many countries there are no national registries. Making patients visible within their respective healthcare systems by implementing means to record their precise diagnoses would make it possible in the future not only to review our estimations, but more fundamentally to improve the adaptation of support and reimbursement policies”, specifies Rath.

Other observations were made during this study, with the researchers showing for example that out of the more than 6,000 diseases described in Orphanet, 72% are genetic and 70% start in childhood. Furthermore, among the diseases analyzed in the study, 149 alone are responsible for 80% of cases of rare diseases identified worldwide.

Future research must now focus on collecting and analyzing the data on the rare diseases which had been excluded from this study. Cancers and other rare diseases caused by infectious agents or linked to environmental factors will be the subject of new analyses. But the researchers’ priority remains the same: namely, to broaden the field of knowledge on rare diseases in order to offer patients better treatment and ensure that, in the future, no-one is left behind.

Stéphanie Nguengang Wakap, Deborah M Lambert, Annie Olry, Charlotte Rodwell, Charlotte Gueydan, Valérie Lanneau, Daniel Murphy, Yann Le Cam, Ana Rath.
Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database.
European Journal of Human Genetics (2019).

0
  • Tweet
Tagged under: healthcare

About arioadmin

What you can read next

Pass savings along to customers and clients with wholesale pharmaceuticals
What is Diabetes?
Can I Get COVID-19 Again?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Types of Diabetes

    Diabetes is a group of deases in which the body...
  • Parallel Trade Definition

    Parallel trade or parallel import in pharmaceut...
  • Unnecessary Medications and Adverse Drug Effects

    Adverse drug effects are especially problematic...
  • Types of Cancer Treatments

    Cancer is a disease in which some of the body&#...
  • What is Diabetes?

    Diabetes is a metabolic disease that develops w...

Recent Comments

    Archives

    • April 2022
    • November 2021
    • October 2021
    • September 2021
    • August 2021
    • October 2019

    Categories

    • Articles
    • News
    • Scientific
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Featured Posts

    • Types of Diabetes

      0 comments
    • Parallel Trade Definition

      0 comments
    • Unnecessary Medications and Adverse Drug Effects

      0 comments
    • Types of Cancer Treatments

      0 comments
    • What is Diabetes?

      0 comments

    ASK FOR YOUR ORDER

    Please fill this for and we'll get back to you as soon as possible!

    FOOTER MENU

    • Home
    • Products
    • Our Services
    • About Us
    • Events
      • ExpoPharm
    • Blog
    • Contact Us

    NEWSLETTER SIGNUP

    By subscribing to our mailing list you will always be update with the latest news from us.

    We never spam!

    GET IN TOUCH

    T +90 (312) 472 87 86
    Email: sales@elisilac.com

    Elis Ilac
    Ahmet Taner Kışlalı Mah. 2879. Sokak. Park Evleri Sitesi 2/2 Çayyolu-Çankaya-Ankara/TURKEY

    Open in Google Maps

    • GET SOCIAL
    Elis Ilac

    © 2019 All rights reserved. Elis Ilac.

    TOP